Companies /Healthcare

Pelthos Therapeutics Inc.

NYSE MKT: PTHS Biotechnology
$22.38
▲ $2.96 (+15.24%) today
Markets closed · 7:06pm ET
Today · % change

Fundamentals

Market Cap
$74.3M
Profit Margin
-199.5%
Revenue (TTM)
$43.3M
EPS (TTM)
$-27.36
52-Week Range
$18 – $38
Street Target
$53.14

About Pelthos Therapeutics

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company is headquartered in Durham, North Carolina.

PTHS Coverage